Failure to Remove IVC Filters Contributing to Rise of IVC Thrombosis

Failure to Remove IVC Filters Contributing to Rise of IVC Thrombosis

The placement of IVC Filters (inferior vena cava filters) without subsequent retrieval may be one of the main reasons that IVC thrombosis is on the rise, according to MedPage Today.

It is estimated that IVC thrombosis accounts for 2.6 to 4.0 percent of deep vein thrombosis cases.

IVC Filter Device
Table of Contents

What is IVC Thrombosis?

IVC thrombosis is an unwanted adverse event that occurs mainly after IVC filter insertion; therefore, IVC filters should only be used for proper indications, and if an IVC filter is inserted, it should be a retrievable type, as the filter needs to come out as soon as possible, as recommended by the FDA.

In August 2010, the FDA issued a warning stating that the agency had received 921 adverse event reports concerning IVC filters.

The FDA has subsequently concluded that the risk of injury may outweigh any potential benefits of implanting IVC filters, and the FDA advised physicians to remove the filters as soon as the danger of blood clots has passed.

The warning was updated in May 2014, when the FDA encouraged all physicians involved in the treatment and follow-up of patients receiving IVC filters to consider the risks and benefits of filter removal for each patient.

At that time, the FDA also required manufacturers to collect additional clinical data addressing safety questions for currently marketed IVC filters in the U.S.

Problems Associated With Non-Removal of IVC Filters

Common complications with IVC filters left in the body for long periods of time include:

  • The progression of DVT
  • Recurrent PE
  • Filter migration
  • Tilt, break, or embolism
  • IVC perforation or occlusion

There are currently no guidelines on the time frame during which IVC filters must be retrieved from the body, and according to the U.S. Food and Drug Administration (FDA), the majority of IVC filters are not retrieved, despite the perceived risk of increased fracture, embolism, and IVC wall penetration.

Written By:
Jessie Paluch
Jessie Paluch

Experienced Attorney & Legal SaaS CEO

With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three.  She spent the first decade of her career working as an international tax attorney at Deloitte.

In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.

In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!

Camp Lejeune Lawsuit

Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.

Tylenol Lawsuit

Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.

AFFF Lawsuit

Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.

Do You
Have A Case?

Here, at TruLaw, we’re committed to helping victims get the justice they deserve.

Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

Helpful Sites & Resources